Thubrikar Aortic Valve, Inc. today announced successful results in the first two patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) using the new Precision 2™ Delivery ...

An analyst earlier this month took aim at what’s behind a big run-up in shares of Irvine medical device maker Edwards Lifesciences Corp.: a new type of heart valve that doesn’t require major surgery.

Pulsed-field ablation, transcatheter heart valves, and IVL are among the top stories, as they drive growth among the largest ...

Irvine-based heart valve maker Edwards Lifesciences Corp. reported what it called positive results from two studies of a new type of valve that doesn’t require major surgery. Shares of Edwards closed ...

NORRISTOWN, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc., announced today that it received approval from a Competent Authority in Poland to conduct initial patient implants with its Optimum ...

TruLeaf from the AllMeD Solutions group, successfully completed the first phase of a first-in-human clinical trial of a revolutionary system for tricuspid and mitral heart valve implantation via ...

Aortic stenosis, a narrowing of the aortic valve opening that restricts blood flow through the heart, is one of the most common and serious heart valve diseases. The aortic valve has three leaflets - ...

Sarasota Memorial Hospital is one of the first hospitals to use a new FDA-approved treatment for failing tricuspid valves. The new procedure is less invasive than traditional surgery and allows ...

Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...

Researchers sought to find the best method for vascular catheter connector valve disinfection and found a five-second scrub with 70 percent isopropyl alcohol may be best, according to a study ...